General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents: Cyprus public contracts since 2024. Since January 2024 the line carries 273 award notices from 3 buyers. 34 suppliers share it. 103 in 2024. 95 in 2025. 75 in the first 9 months of 2026. 8 of them had no award notice in the register from November 2023 to 2024.
Assay record ASY-CY-0NZV7GE1MF · Cite as: Assay Systems, “General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents: Cyprus public contracts since 2024”, https://assay-systems.com/register/cy/line/general-anti-infectives-for-systemic-use-vaccines-antineoplastic-and-immunodulating-agents/
Since January 2024 the line carries 273 award notices from 3 buyers. 34 suppliers share it.
103 in 2024. 95 in 2025. 75 in the first 9 months of 2026.
8 of them had no award notice in the register from November 2023 to 2024.
1 more supplier in the line is not listed here, because their register name may be the name of a private person.
Names every buyer behind the figures and, for each award notice, the supplier, the award date, the notice number and the value where one is disclosed, and the notices behind every figure.
Share of the line held by each of its largest suppliers, by number of award notices, in the TED register for Cyprus.
Source: contract award notices for Cyprus in Tenders Electronic Daily (TED), Publications Office of the European Union, ted.europa.eu, reusable for commercial purposes under Commission Decision 2011/833/EU; notices from November 2023, when TED began to publish the winning supplier, to 30 September 2026, accessed 11 October 2026.Assay Systems has changed the data.